IMB Dx, Inc. (KOSDAQ:461030)
South Korea · Delayed Price · Currency is KRW 6,710.00
-190.00 (-2.75%)
Mar 12, 2026, 2:14 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 96.72 billion as of March 11, 2026. Its market cap has decreased by -44.71% in one year.
Market Cap
96.72B
Enterprise Value
73.88B
Revenue
4.26B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,710.00
Market Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 96.72B, a decrease of -80.80%. That is a compound annual growth rate of -57.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 96.72B | -30.23% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 228.31B |
| Vaxcell-Bio Therapeutics | 190.71B |
| Macrogen | 178.34B |
| MedPacto | 175.83B |
| ENCell | 167.87B |
| iNtRON Biotechnology | 143.46B |
| CG Invites | 109.96B |
| Amicogen | 96.80B |